*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
The Role of HSP72 in Patient with Graves ‘disease and Non-autoimmune Hyperthyroidism in AL-Najaf Province

Author: EMAN NADHAIF, MUHAMED ALI S. AL KABE, ISRAAKETABAL YASIRI, ZAYTOON A. ALKHAFAJI
Abstract: Graves ' disease (GD) is an autoimmune thyroid disease defined by the production of stimulating autoantibodies to the thyroid-stimulating hormone receptor (TSHR) (TSAb) that induce a sustained state of hyperthyroidism in patients. This study aimed to evaluate the role of Heat Shock Protein 72 "HSP72” in patients with Graves' disease in comparison with other non-autoimmune hyperthyroidism in AL-Najaf province. A case control study included patients with early diagnosis of thyrotoxicosis were randomly selected in endocrine center/Al Sadder Medical city. Whole blood samples were collected from 60 patients and sent into thebiochemistry department of internal Laboratory of AL-Sadder Medical City/ Najaf/Iraq, from the period between Sep. 2017 till Apr. 2018. Hyperthyroidism patients were subdivided into two groups: Autoimmune hyperthyroidism "Graves' disease" patients group and Nonautoimmune hyperthyroidism patients group, depending on Anti-TSHR Abs and Anti-TPO Abs. Healthy control group of 40 people who had no history or clinical evidence of hyperthyroidism or any chronic disease. Patients with hyperthyroidism under treatment and pregnant women were excluded from the study. The parameter studied in this work was: Heat Shock Protein 72 "HSP72". Our study showed that significant difference (P=0.05) between Graves’ disease patients, non-autoimmune hyperthyroidism patients and healthy control groups (114.8279, 110.7479 and 67.7500, respectively). In anti-HSP72 antibody that has been detected in sera of Graves' disease patients. levels of antihsp72 antibodies demonstrated in GD patients had higher index than that of control subjects. However, the absence of a correlation with disease severity or activity makes it unlikely that hsp72 antibodies play an important role in the pathogenesis of GD.hsp72 antibody should be investigated thoroughly to correlate it along with the prognosis and severity of GD.
Keyword: hsp72 antibody,autoimmune disease, Grave’s Disease.
DOI: https://doi.org/10.31838/ijpr/2019.11.02.033
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free